Merit Medical Systems Inc
MMSI87.390USD
-0.240-0.27%
Cierre 12/24, 16:00（ET）Cotizaciones retrasadas 15 min
5.18BCap. mercado
43.52P/E TTM
Más Datos de Merit Medical Systems Inc Compañía
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Información de Merit Medical Systems Inc
Símbolo de cotizaciónMMSI
Nombre de la empresaMerit Medical Systems Inc
Fecha de salida a bolsaOct 22, 2090
Director ejecutivoAronson (Martha Goldberg)
Número de empleados7400
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 22
Dirección1600 West Merit Park Way
CiudadSOUTH JORDAN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84095
Teléfono18012531600
Sitio Webhttps://www.merit.com/
Símbolo de cotizaciónMMSI
Fecha de salida a bolsaOct 22, 2090
Director ejecutivoAronson (Martha Goldberg)
Ejecutivos de Merit Medical Systems Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
227.08M
59.37%
International
155.38M
40.63%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
Estadísticas de accionistas
Actualizado: mar., 18 de nov
Actualizado: mar., 18 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Otro
64.97%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Otro
64.97%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
54.11%
Investment Advisor/Hedge Fund
32.95%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.31%
Individual Investor
2.26%
Pension Fund
1.63%
Sovereign Wealth Fund
1.02%
Family Office
0.40%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Nomura Investment Management Business Trust
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Institutional Asset Management
1.09M
1.85%
-3.11K
-0.28%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
Ver más
Invesco S&P SmallCap Health Care ETF
Proporción3.18%
First Trust Indxx Medical Devices ETF
Proporción2.22%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.76%
Thrivent Small-Mid Cap ESG ETF
Proporción0.91%
Invesco S&P SmallCap Low Volatility ETF
Proporción0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.71%
OneAscent Enhanced Small and Mid Cap ETF
Proporción0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.67%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.66%
Franklin US Small Cap Multifactor Index ETF
Proporción0.66%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Merit Medical Systems Inc?
Los cinco principales accionistas de Merit Medical Systems Inc son:
BlackRock Institutional Trust Company, N.A. posee 7.97M acciones, lo que representa el 13.46% del total de acciones.
The Vanguard Group, Inc. posee 6.82M acciones, lo que representa el 11.51% del total de acciones.
State Street Investment Management (US) posee 2.22M acciones, lo que representa el 3.75% del total de acciones.
Conestoga Capital Advisors, LLC posee 2.21M acciones, lo que representa el 3.73% del total de acciones.
Fuller & Thaler Asset Management Inc. posee 1.82M acciones, lo que representa el 3.07% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 7.97M acciones, lo que representa el 13.46% del total de acciones.
The Vanguard Group, Inc. posee 6.82M acciones, lo que representa el 11.51% del total de acciones.
State Street Investment Management (US) posee 2.22M acciones, lo que representa el 3.75% del total de acciones.
Conestoga Capital Advisors, LLC posee 2.21M acciones, lo que representa el 3.73% del total de acciones.
Fuller & Thaler Asset Management Inc. posee 1.82M acciones, lo que representa el 3.07% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Merit Medical Systems Inc?
Los tres principales tipos de accionista de Merit Medical Systems Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Merit Medical Systems Inc (MMSI)?
A fecha de 2025Q3, 736 instituciones poseen acciones de Merit Medical Systems Inc, con un valor de mercado combinado de aproximadamente 64.29M, lo que representa el 108.43% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -2.37%.
¿Cuál es la mayor fuente de ganancias de Merit Medical Systems Inc?
El FY2025Q2, el segmento empresarial Peripheral Intervention generó la ganancia más alta para Merit Medical Systems Inc, ascendiendo a 142.85M y representando el 37.35% de la ganancia total.
